Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

A Phase I Qualitative Study to Develop a Patient-Reported Experience Measure for Adolescents and Adults Receiving Gender-Affirming Treatments

FY 2020-21

Summary
Transgender and gender diverse individuals often face stigma within healthcare settings and represent an underserved patient population within Canada and abroad. For those able to access care, existing treatments can dramatically alter appearance as well as function to allow transgender patients to feel more comfortable within their own bodies. However, the impact of known financial, cultural, and systemic barriers on the transgender patient care experience remains unclear and underreported in the existing literature. To address this limitation, patient-reported experience measures (PREMs) can be developed to identify and evaluate factors that interfere with optimal healthcare delivery from the patient perspective. As such, the primary objective of this international, multicenter, qualitative study is to identify concepts of interest to transgender individuals seeking gender-affirming treatment(s) (GATs) to inform the development of a treatment-specific PREM. This PREM for GATs will comprise of independently functioning scales and will be developed over 3 phases. In phase 1 (focus of this proposal), we will conduct a series of interviews to elicit concepts related to the patient experience seeking GATs. Transgender men and women aged 16 and older, at participating institutions in Canada, USA, Denmark, and the Netherlands will be invited to participate. Patient interviews will be digitally recorded, transcribed, and coded. The outcome of this phase 1 study will be the development of preliminary patient experience scales. In phase 2 and 3, the measurement properties of these scales will be established. Once completed, a GAT-specific PREM will enable clinicians to better recognize healthcare barriers and guide quality improvement initiatives for transgender patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449717
Name
Gallo Lucas
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A Phase I Qualitative Study to Develop a Patient-Reported Experience Measure for Adolescents and Adults Receiving Gender-Affirming Treatments
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Gender; Patient-Reported Experience Measures; Plastic Surgery; Transgender
Abstract
Transgender and gender diverse individuals often face stigma within healthcare settings and represent an underserved patient population within Canada and abroad. For those able to access care, existing treatments can dramatically alter appearance as well as function to allow transgender patients to feel more comfortable within their own bodies. However, the impact of known financial, cultural, and systemic barriers on the transgender patient care experience remains unclear and underreported in the existing literature. To address this limitation, patient-reported experience measures (PREMs) can be developed to identify and evaluate factors that interfere with optimal healthcare delivery from the patient perspective. As such, the primary objective of this international, multicenter, qualitative study is to identify concepts of interest to transgender individuals seeking gender-affirming treatment(s) (GATs) to inform the development of a treatment-specific PREM. This PREM for GATs will comprise of independently functioning scales and will be developed over 3 phases. In phase 1 (focus of this proposal), we will conduct a series of interviews to elicit concepts related to the patient experience seeking GATs. Transgender men and women aged 16 and older, at participating institutions in Canada, USA, Denmark, and the Netherlands will be invited to participate. Patient interviews will be digitally recorded, transcribed, and coded. The outcome of this phase 1 study will be the development of preliminary patient experience scales. In phase 2 and 3, the measurement properties of these scales will be established. Once completed, a GAT-specific PREM will enable clinicians to better recognize healthcare barriers and guide quality improvement initiatives for transgender patients.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gallo, Lucas
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~